In this executive summary download, experts from Lonza explore the key factors involved in ensuring the safe handling of ADCs, including toxicological assessment, risk assessment, best practices for containment, and occupational hygiene monitoring.
By clicking "Access Content" you agree to our Legal Disclaimer and the Lonza Privacy and Cookies Policy.

Latest content

Latest briefing from the Knowledge Center

Poster
Bioanalytical Challenges in the Development and Validation of Bioassays used in Cell Therapy
Authors: Roland J.W. Meesters, PhD, Scientist II, Cell and Gene Therapy Development Services Ravi...
Our Environment - AR
Article
Strategies to Improve Environmental Sustainability via Wastewater Incineration Reduction and Solvent...
In the webinar, Environmental Sustainability at Lonza - Wastewater Incineration Reduction," ; Dr....
Webinar (on-demand)
Bring your mRNA sequence to life by engaging early in process development 
Developing a scalable, robust, and economically viable process that delivers high quality mRNA...
Sustainability webinar
Webinar (on-demand)
Environmental Sustainability at Lonza Small Molecules - Use Case: Solvent Recovery
Sustainability is at the forefront of the way Lonza runs its business. Thanks to its Vision Zero...
KC Video thumbnail
Webinar (on-demand)
Improved and Rebalanced Helper and RepCap Plasmids to Ramp up your AAV Productivity
Strong growth in the recombinant AAV (rAAV)-based gene therapy sector is creating a need for...
Poster
Optimization of Packaging Efficiency for Adeno-Associated Virus by Evaluating Production Process...
Author: Tsai-Yu Chen, PhD, Senior Scientist, Process Development Abstract: The packaging...
micro image
Poster
Comparison between Droplet Digital PCR and Quantitative PCR for Adeno-Associated Virus Infectious...
Author: Tam Duong, PhD, Scientist II, R&D Abstract: Recombinant adeno-associated virus (rAAV) has...
AAV manufacturing
Poster
A New Two-Dimensional Droplet Digital PCR Method for AAV Intact Viral Genome Titer Analysis
Author: Tam Duong, PhD, Scientist II, R&D Abstract: Recombinant adeno-associated virus (rAAV) has...
Poster
A Streamlined Downstream Purification Platform Process for Adeno-Associated Viral Vectors
Author: F. Michael Haller, PhD, Principal Scientist, R&D Abstract: One major obstacle to achieving...
Poster
A Comprehensive Characterization of Full, Partial, and Empty Lentiviral Vectors
Author: Vijetha Bhat, MS, Scientist II, R&D Abstract: Lentiviral vectors are biological vehicles...
Cocoon device
Webinar (on-demand)
Choosing versatile and scalable platforms for cell therapy manufacturing
Speaker: Peter Yates, Ph.D, Product Management Director, Personalized Medicine As cell therapies...
lab workers on tablet
Podcast
CMC Challenges in the Evolving Small Molecule Development Pipeline
A growing proportion of drugs in the development pipeline nowadays start out life at small biotech...